KAS
EW icon

Kemnay Advisory Services’s Edwards Lifesciences EW Stock Holding History

Kemnay Advisory Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.7K Sell
233
-87
-27% -$7.17K ﹤0.01% 731
2025
Q4 		$27.3K Buy
+320
New +$26.3K ﹤0.01% 458

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Kemnay Advisory Services's EW Position: Q1 2026 in Review

Kemnay Advisory Services reduced its Edwards Lifesciences (EW) stake by 27% in Q1 2026, selling an estimated $7.17K and leaving 233 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

Kemnay Advisory Services first reported a position in EW in Q4 2025 and has held it in 2 quarters since. The position peaked at $27.3K in Q4 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Kemnay Advisory Services held 233 shares of Edwards Lifesciences worth $18.7K as of Q1 2026.
  • Kemnay Advisory Services sold 87 Edwards Lifesciences shares in Q1 2026, an estimated $7.17K.
  • Edwards Lifesciences made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q1 2026, its #731 holding.
  • Kemnay Advisory Services first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 2 quarters since.
  • Kemnay Advisory Services's Edwards Lifesciences position peaked at $27.3K in Q4 2025.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.